Financial News Conference Full Year 2017 results

Location: Leverkusen, Baykomm (Bayer‘s Communication Center)

Bayer: business at prior-year level – on track with strategy

Group sales increased by 1.5 percent (Fx & portfolio adj.) to 35.015 billion euros / Another record year for Pharmaceuticals / Weak business development at Consumer Health / Crop Science business down against prior year due to situation in Brazil – measures taking effect / EBITDA before special items level year on year at 9.288 billion euros / EBITDA before special items level year on year at 9.288 billion euros / Core earnings per share increased by 1.0 percent to 6.74 euros / Covestro deconsolidated – additional cash inflows of 4.7 billion euros / Monsanto acquisition expected to close in second quarter of 2018 / Group outlook for 2018: increase in sales (Fx & portfolio adj.), EBITDA before special items and core earnings per share at prior-year level due to currency effects
MORE

Links

Annual Report 2017

Speaker

Follow us:

   You will find more news from @Bayer on » Twitter